Home / Publications / Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens
JOIN US ON
Related Publications
Explore our collection of related articles to learn more about the science of sleep, tips for improving sleep quality, and insights from our latest research at the Sleep Clinic.
Home / Publications / Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens
JOIN US ON
Journal Articles
Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens
The ADVANCE trial, a pivotal study in the field of HIV treatment, provides comprehensive insights into the efficacy and safety of three WHO-recommended first-line antiretroviral regimens over a 192-week period. Start Reading
In her latest discourse, Dr. Nomathemba Chandiwana, Principal Scientist at Ezintsha, University of the Witwatersrand, delves into the critical intersection of sleep. . .
We are pleased to share insights from Dr. Nomathemba Chandiwana's recent presentation, "Lessons from the HIV Epidemic for the Obesity Pandemic," delivered. . .
